It is not possible to get approval for one drug based on the trial of another drug. More likely the FDA says ok we accept your data and excuses, you may move on to phase 3, upon successful completion of phase 3 you will have approval, dont f* it up this time.
- Forums
- ASX - By Stock
- BOT
- Bot Chart
Bot Chart, page-3299
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
33.5¢ |
Change
-0.005(1.47%) |
Mkt cap ! $608.8M |
Open | High | Low | Value | Volume |
33.5¢ | 34.3¢ | 32.5¢ | $1.200M | 3.588M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 349093 | 33.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.5¢ | 25403 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 333942 | 0.330 |
10 | 854807 | 0.325 |
10 | 499198 | 0.320 |
9 | 424099 | 0.315 |
26 | 895152 | 0.310 |
Price($) | Vol. | No. |
---|---|---|
0.335 | 25403 | 5 |
0.340 | 409008 | 9 |
0.345 | 427139 | 8 |
0.350 | 423142 | 11 |
0.355 | 364833 | 3 |
Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
3DA
AMAERO INTERNATIONAL LTD
Hank Holland, Executive Chairman and CEO
Hank Holland
Executive Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online